E. C. Beuvery

2.2k total citations
79 papers, 1.7k citations indexed

About

E. C. Beuvery is a scholar working on Molecular Biology, Microbiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, E. C. Beuvery has authored 79 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 26 papers in Microbiology and 21 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in E. C. Beuvery's work include Bacterial Infections and Vaccines (26 papers), Monoclonal and Polyclonal Antibodies Research (21 papers) and Viral Infectious Diseases and Gene Expression in Insects (20 papers). E. C. Beuvery is often cited by papers focused on Bacterial Infections and Vaccines (26 papers), Monoclonal and Polyclonal Antibodies Research (21 papers) and Viral Infectious Diseases and Gene Expression in Insects (20 papers). E. C. Beuvery collaborates with scholars based in Netherlands, Guinea-Bissau and United States. E. C. Beuvery's co-authors include Daan J.A. Crommelin, Wim Jiskoot, Dirk E. Martens, J. Tramper, J. Nagel, Tom Teerlink, Gideon Kersten, C. D. de Gooijer, G. I. Tesser and J. Peeters and has published in prestigious journals such as The Journal of Experimental Medicine, Analytical Biochemistry and Journal of Controlled Release.

In The Last Decade

E. C. Beuvery

78 papers receiving 1.6k citations

Peers

E. C. Beuvery
Ken S. Rosenthal United States
Hugo D. Meiring Netherlands
Rameshwar U. Kadam United States
Andreas Frey Germany
Peter Hoogerhout Netherlands
E. C. Beuvery
Citations per year, relative to E. C. Beuvery E. C. Beuvery (= 1×) peers Martine Pugnière

Countries citing papers authored by E. C. Beuvery

Since Specialization
Citations

This map shows the geographic impact of E. C. Beuvery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. C. Beuvery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. C. Beuvery more than expected).

Fields of papers citing papers by E. C. Beuvery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. C. Beuvery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. C. Beuvery. The network helps show where E. C. Beuvery may publish in the future.

Co-authorship network of co-authors of E. C. Beuvery

This figure shows the co-authorship network connecting the top 25 collaborators of E. C. Beuvery. A scholar is included among the top collaborators of E. C. Beuvery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. C. Beuvery. E. C. Beuvery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Streefland, Mathieu, Bas van de Waterbeemd, Leo A. van der Pol, et al.. (2009). A practical approach for exploration and modeling of the design space of a bacterial vaccine cultivation process. Biotechnology and Bioengineering. 104(3). 492–504. 20 indexed citations
2.
Sprang, Eric N.M. van, Mathieu Streefland, Henk‐Jan Ramaker, et al.. (2007). Manufacturing Vaccines: An Illustration of Using PAT Tools for Controlling the Cultivation of Bordetella pertussis. Quality Engineering. 19(4). 373–384. 7 indexed citations
3.
Baart, Gino, Bert Zomer, Leo A. van der Pol, et al.. (2007). Modeling Neisseria meningitidis metabolism: from genome to metabolic fluxes. Genome biology. 8(7). R136–R136. 58 indexed citations
4.
Piirainen, Liisa, et al.. (1997). Immunogenicity of a pilot inactivated poliovirus vaccine with trypsin-treated type 3-component. Vaccine. 15(2). 237–243. 6 indexed citations
5.
Wieten, G., et al.. (1997). Current good manufacturing practice in plant automation of biological production processes. Cytotechnology. 23(1-3). 19–28. 8 indexed citations
6.
Gooijer, C. D. de, et al.. (1996). On-line estimation of the biomass activity during animal-cell cultivations. Biotechnology and Bioengineering. 51(2). 206–214. 18 indexed citations
7.
Kersten, Gideon, et al.. (1995). Immunogenicity of Trypsin treated Type 2 and Type 3 Poliovirus in Rats. Biologicals. 23(2). 179–183. 7 indexed citations
8.
Martens, Dirk E., et al.. (1993). Effect of dilution rate on growth, productivity, cell cycle and size, and shear sensitivity of a hybridoma cell in a continuous culture. Biotechnology and Bioengineering. 41(4). 429–439. 58 indexed citations
9.
Ressing, Maaike E., Wim Jiskoot, H. Talsma, et al.. (1992). The Influence of Sucrose, Dextran, and Hydroxypropyl-β-cyclodextrin as Lyoprotectants for a Freeze-Dried Mouse IgG2a Monoclonal Antibody (MN12). Pharmaceutical Research. 9(2). 266–270. 49 indexed citations
10.
Beuvery, E. C., et al.. (1992). The potential of flow cytometric analysis for the characterization of hybridoma cells in suspension cultures. Cytotechnology. 8(1). 65–74. 11 indexed citations
11.
Koolwijk, Pieter, et al.. (1991). An isotype-specific spot-ELISA for the enumeration of antibody-secreting hybridomas and the determination of isotype switch variants. Journal of Immunological Methods. 145(1-2). 11–18. 8 indexed citations
12.
Jiskoot, Wim, et al.. (1991). Preparation of clinical grade monoclonal antibodies from serum-containing cell culture supernatants. Journal of Immunological Methods. 138(2). 273–283. 30 indexed citations
13.
Beuvery, E. C., et al.. (1990). Characterization of Antibody Labelled Colloidal Gold Particles and Their Applicability in a Sol Particle Immuno Assay (SPIA). Journal of Immunoassay. 11(1). 31–47. 19 indexed citations
14.
Jiskoot, Wim, et al.. (1989). Two-step purification of a murine monoclonal antibody intended for therapeutic application in man. Journal of Immunological Methods. 124(1). 143–156. 27 indexed citations
15.
Speijers, G.J.A., L. H. J. C. Danse, Magda A. M. Krajnc-Franken, et al.. (1989). Subacute toxicity of Zwittergent administered intramuscularly. Vaccine. 7(4). 364–368. 6 indexed citations
16.
Vries, Petra de, Rob van Binnendijk, P. van der Marel, et al.. (1987). Inhibition of Measles Virus-Induced Cell—Cell Fusion with a Monoclonal Antibody Directed Against the Haemagglutinin. Viral Immunology. 1(1). 25–34. 10 indexed citations
18.
Teerlink, Tom, et al.. (1987). Antigenic and immunogenic properties of cyanogen bromide peptides from a serotype 5 gonococcal outer membrane protein I. Antonie van Leeuwenhoek. 53(6). 493–499. 1 indexed citations
20.
Vliegenthart, J.F.G., et al.. (1983). Isolation and partial characterization of meningococcal group H, I and K polysaccharides. Data Archiving and Networked Services (DANS). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026